Sodium is globally available, which makes a sodium-ion rechargeable battery preferable to a lithium-ion battery for large-scale storage of electrical energy, provided a host cathode for Na can be found that provides the necessary capacity, voltage, and cycle life at the prescribed charge/discharge rate. Low-cost hexacyanometallates are promising cathodes because of their ease of synthesis and rigid open framework that enables fast Na(+) insertion and extraction. Here we report an intriguing effect of interstitial H2O on the structure and electrochemical properties of sodium manganese(II) hexacyanoferrates(II) with the nominal composition Na2MnFe(CN)6·zH2O (Na2-δMnHFC). The newly discovered dehydrated Na2-δMnHFC phase exhibits superior electrochemical performance compared to other reported Na-ion cathode materials; it delivers at 3.5 V a reversible capacity of 150 mAh g(-1) in a sodium half cell and 140 mAh g(-1) in a full cell with a hard-carbon anode. At a charge/discharge rate of 20 C, the half-cell capacity is 120 mAh g(-1), and at 0.7 C, the cell exhibits 75% capacity retention after 500 cycles.
Prussian blue and its analogues consisting of different transitionmetal ions (Fe, Mn, Ni, Cu, Co and Zn) have been synthesized at room temperature. Insertion of Na into KFe 2 (CN) 6 in a carbonate electrolyte exhibited a reversible capacity near 100 mA h g À1 with no capacity fade in 30 cycles. The data indicate that a Na-ion battery with a Prussian blue framework as a cathode will be feasible.
general public and 526 nurses (i.e., 234 front-line nurses and 292 non-front-line nurses) to evaluate vicarious traumatization scores via a mobile appbased questionnaire. Front-line nurses are engaged in the process of providing care for patients with COVID-19. The results showed that the vicarious traumatization scores for front-line nurses including scores for physiological and psychological responses, were significantly lower than those of non-front-line nurses (P < 0.001). Interestingly, the vicarious traumatization scores of the general public were significantly higher than those of the front-line nurses (P < 0.001); however, no statistical difference was observed compared to the scores of nonfront-line nurses (P > 0.05). Therefore, increased attention should be paid to the psychological problems of the medical staff, especially non-front-line nurses, and general public under the situation of the spread and control of COVID-19. Early strategies that aim to prevent and treat vicarious traumatization in medical staff and general public are extremely necessary.
Osteogenesis during bone modeling and remodeling is coupled with angiogenesis. A recent study shows that the specific vessel subtype, strongly positive for CD31 and Endomucin (CD31hiEmcnhi), couples angiogenesis and osteogenesis. We found that preosteoclasts secrete platelet derived growth factor-BB (PDGF-BB), inducing CD31hiEmcnhi vessels during bone modeling and remodeling. Mice with depletion of PDGF-BB in tartrate-resistant acid phosphatase positive (TRAP+) cell lineage (Pdgfb–/–) show significantly lower trabecular and cortical bone mass, serum and bone marrow PDGF-BB concentrations, and CD31hiEmcnhi vessels compared to wild-type mice. In the ovariectomized (OVX) osteoporotic mouse model, concentrations of serum and bone marrow PDGF-BB and CD31hiEmcnhi vessels are significantly decreased. Inhibition of cathepsin K (CTSK) increases preosteoclast numbers, resulting in higher levels of PDGF-BB to stimulate CD31hiEmcnhi vessels and bone formation in OVX mice. Thus, pharmacotherapies that increase PDGF-BB secretion from preosteoclasts offer a novel therapeutic target for osteoporosis to promote angiogenesis for bone formation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.